Collectives: interstitial lung diseases (ILD), pulmonary hypertension (PH), COPD, ALI/ARDS, pneumonia, lung cancer
Specimens: Blood (EDTA, serum, plasma, Paxgene), bronchoalveolar lavage (BAL), lung tissue (fresh frozen, FFPE) from explanted lungs, surgical resections or transbronchial biopsies, primary cells, respiratory condensates (EBC)
Services/biospecimen processing: primary cell isolations (vascular smooth muscle cells/SMC, interstitial and adventitia fibroblasts, type 2 pnemocytes/AEC2, precision cut lung slices (PCLS))
Numbers: >1000 patients in the field of DPLD (IPF, sarcoidosis, exogenous allergic alveolitis), PH, ARDS/ALI and pneumonia (liquid biosamples) >660 explanted lungs (fibrosis ~240, PH ~110, COPD ~90, donors ~100, other entities ~130)
Biobank Information and Management System (BIMS): StarLIMS
IT: european IPF registry/european ILD registry (eurIPFreg: Secutrial®/ eurILDreg: Redcap), UGMLC patient registry/phenotyoisation platform (Redcap, under construction), DZL data warehouse (i2b2)
Networks: DZL-Biobank Platform
